Citigroup reissued their buy rating on shares of Boston Scientific (NYSE:BSX – Free Report) in a research note issued to investors on Thursday morning, Benzinga reports. Citigroup currently has a $63.00 price objective on the medical equipment provider’s stock. BSX has been the topic of a number of other research reports. Oppenheimer lifted their target […]
Dubuque Bank & Trust Co. increased its stake in Boston Scientific Co. (NYSE:BSX – Free Report) by 7.4% in the 2nd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 5,488 shares of the medical equipment provider’s stock after purchasing an additional 376 shares during the […]
Needham & Company LLC restated their buy rating on shares of Boston Scientific (NYSE:BSX – Free Report) in a research note released on Wednesday morning, Benzinga reports. Needham & Company LLC currently has a $61.00 price objective on the medical equipment provider’s stock. BSX has been the topic of several other reports. Morgan Stanley started […]
Boston Scientific (NYSE:BSX – Get Free Report) issued an update on its FY 2023 earnings guidance on Thursday morning. The company provided earnings per share guidance of $1.96-$2.00 for the period, compared to the consensus earnings per share estimate of $1.99. The company issued revenue guidance of $14.00 billion-$14.00 billion, compared to the consensus revenue […]
Boston Scientific (NYSE:BSX – Get Free Report) had its target price boosted by Barclays from $59.00 to $60.00 in a report released on Friday, FlyOnTheWall reports. Barclays‘s target price suggests a potential upside of 11.15% from the company’s previous close. Several other research analysts have also commented on the stock. TheStreet upgraded shares of Boston […]